Edition:
United States

Entest Biomedical Inc (ENTB.PK)

ENTB.PK on OTC Markets Group

0.03USD
15 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.03
Day's Low
$0.03
Volume
13,853
Avg. Vol
50,199
52-wk High
$0.06
52-wk Low
$0.01

Chart for

About

Entest BioMedical, Inc. is engaged in the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is engaged in the development and commercialization of ImenVax, a therapeutic cancer vaccine for use in canines, and... (more)
No analyst recommendations are available for .

Overall

Beta: -3.41
Market Cap(Mil.): $1.48
Shares Outstanding(Mil.): 49.17
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.82 16.04
EPS (TTM): -- -- --
ROI: -- 7.96 34.69
ROE: -- 11.65 15.46

Earnings vs. Estimates

No consensus analysis data available.